Acne: History and Discovery

Acne is one of the oldest documented human ailments, described in ancient Egyptian medical papyri and by the physicians of Greece and Rome long before anyone understood its cause. Its very name carries a thousand-year-old riddle: most scholars trace the modern word back to a single miscopied letter in a sixth-century Byzantine manuscript, where the Greek akmē ("point" or "prime of life") appears to have been written as aknē. From that scribal accident, through the careful classifications of the early-1800s dermatologists Robert Willan and Thomas Bateman, to the modern four-factor model of sebum, follicular plugging, the skin bacterium now called Cutibacterium acnes, and inflammation, this page traces how a near-universal condition of adolescence was named, understood, and finally treated. Acne is extraordinarily common and is not caused by being "dirty" or by personal failing; this history is offered with respect for everyone who has lived with its visible and emotional weight.

Table of Contents

  1. Acne in Antiquity: Egypt, Greece, and Rome
  2. The Name "Acne": A Scribal Error in Aetius of Amida
  3. From the Byzantine and Medieval World to the Renaissance
  4. Willan and Bateman: Naming the Disease in Modern Dermatology
  5. Discovering the Cause: Sebum, Follicles, and Bacteria
  6. The Bacterium: From Propionibacterium to Cutibacterium acnes
  7. The Hormonal Link: Androgens and the Sebaceous Gland
  8. Treatment Milestones: Peroxide, Antibiotics, and Isotretinoin
  9. Stigma, Psychology, and a More Humane Modern View
  10. Research Papers and References
  11. Connections

Acne in Antiquity: Egypt, Greece, and Rome

Acne is genuinely ancient. The earliest plausible references appear in Egyptian medical papyri — most famously the Ebers Papyrus, a compilation usually dated to around 1550 BCE — which records remedies for pustules, sores, and inflammatory swellings of the skin. Some authors have argued that an Egyptian word read as aku-t referred to skin eruptions of this kind, and have even proposed it as a distant root of the modern name; this Egyptian-origin idea is best treated as a hypothesis rather than an established fact, because the dominant and far better-attested etymology runs through Greek (discussed in the next section). What is not in doubt is that the Egyptians recognized and tried to treat boil-like and pustular skin lesions thousands of years ago.

The physicians of classical Greece and Rome described what we would now call acne, though they did not use that word and did not group the lesions exactly as we do. The Roman encyclopaedist Aulus Cornelius Celsus, writing in the first century CE, used the Latin term varus for small, hard, pimple-like eruptions, a word that would shadow acne in the medical vocabulary for centuries (the species name acne vulgaris and the old synonym varus both descend from this tradition). The great Greek physician Galen, in the second century CE, discussed eruptions he called ionthos and recommended purges and topical preparations. These ancient categories were broad and overlapping, lumping together several skin conditions, but they show that the affliction was familiar and that physicians were actively trying to understand and treat it.

Later in the Roman world, the fourth-century physician Theodorus Priscianus — author of a Latin medical handbook — is among the writers cited in histories of dermatology for discussing facial eruptions and their remedies, reflecting a continuing practical interest in the complexion. Across all of these sources the treatments were what the era could offer: dietary advice, sulphur and mineral preparations, astringent washes, and the near-universal recommendation to bathe and scrub — an approach that, as we now know, reflects a long-standing and mistaken assumption that acne is fundamentally a problem of dirt.

Back to Table of Contents

The Name "Acne": A Scribal Error in Aetius of Amida

The story of the word "acne" is one of the most quoted anecdotes in the history of dermatology, and it is a genuine and well-supported account rather than a folk myth. The trail leads to Aetius of Amida, a Greek-speaking Byzantine physician of the sixth century CE who compiled a vast sixteen-book medical encyclopaedia drawing on earlier authorities. In discussing facial eruptions, Aetius used a Greek term related to akmē (ἀκμή), meaning a "point," "peak," or the "prime/flowering of life" — an apt word for blemishes that erupt to a head and that appear, above all, at the peak of youth.

The widely accepted explanation is that, somewhere in the long chain of hand-copied manuscripts that preserved Aetius's work, the word akmē (ἀκμή) was miswritten as aknē (ἀκνή) — the single Greek letter mu (μ) being copied as nu (ν). Because subsequent scholars worked from these corrupted copies, the erroneous form took on a life of its own. The mistaken spelling was effectively a scribe's slip that nobody caught, and it is from this corrupted reading — not from the original, correct Greek — that the term entered the later Latin and modern medical vocabularies.

It is worth being precise about what is firmly established and what is interpretive here. That Aetius used a word in the akmē family, and that the surviving form behind "acne" reflects a copying corruption of it, is the standard scholarly account repeated across modern dermatology histories. The exact manuscript at which the slip first occurred, and the precise century in which the corrupted form became fixed, are matters of textual scholarship rather than settled certainty. The essential point — that our everyday word for this condition very likely owes its spelling to an ancient copyist's error — is one of the more charming accidents in medical language.

Back to Table of Contents

From the Byzantine and Medieval World to the Renaissance

Through the Byzantine, Islamic, and medieval European centuries, knowledge of skin eruptions was preserved and transmitted largely by compiling and commenting on the classical authorities rather than by fresh investigation. The encyclopaedic works of Aetius and other Byzantine physicians were copied and translated; physicians of the medieval Islamic world preserved and extended Greek medicine; and the Latin West inherited the vocabulary of varus and related terms for pimples and facial blemishes. Acne in this long era remained a recognized cosmetic and medical nuisance treated with the same broad toolkit of washes, sulphur, herbal applications, dietary regimens, and bloodletting.

Because the condition was understood through inherited categories that mixed several skin diseases together, there was no clear separation of acne from other pustular or inflammatory eruptions, and a single "pimple" might be grouped with very different complaints. This conceptual blurriness persisted into the Renaissance and early-modern period, when herbals continued to describe remedies for spots and a poor complexion without isolating acne as a distinct disease with a distinct mechanism. The framework needed to define it precisely — classifying skin diseases by how they actually look and behave rather than by ancient humoral theory — would only arrive at the very start of the nineteenth century, in Britain, with the work that effectively founded modern dermatology as an organized discipline.

Back to Table of Contents

Willan and Bateman: Naming the Disease in Modern Dermatology

The figure most responsible for bringing order to the chaos of skin-disease names was Robert Willan (1757–1812), an English physician often called the father of modern dermatology. Willan's great contribution was to classify cutaneous diseases by the appearance of their primary lesions — papules, pustules, scales, vesicles, and so on — rather than by speculative internal causes. His major treatise, On Cutaneous Diseases, began appearing from 1798 onward but was left unfinished at his death in 1812. Within this systematic scheme, acne was treated as a defined entity, helping to lift it out of the older tangle of overlapping terms.

Willan's work was completed and popularized by his pupil and successor Thomas Bateman (1778–1821), whose widely read A Practical Synopsis of Cutaneous Diseases (first published 1813) carried the Willan classification to a broad medical audience across Britain, Europe, and America. It is through the Willan–Bateman tradition that "acne" became established in the modern medical vocabulary as the standard name for the condition, and that physicians began to recognize and name its different forms. The familiar clinical subtypes — for example what later writers would call comedonal, papulopustular, and the severe nodular or "conglobate" forms — grew out of this nineteenth-century effort to describe and subdivide what the eye could see.

The importance of this step is easy to underestimate. Before a disease can be studied, treated rationally, or compared from patient to patient and country to country, it has to be defined and named in a way physicians agree on. By giving acne a clear place in a logical classification of skin diseases, Willan and Bateman turned a vaguely understood complaint into a discrete clinical entity — the necessary foundation for everything that followed, including the search for its actual cause.

Back to Table of Contents

Discovering the Cause: Sebum, Follicles, and Bacteria

Once acne was clearly defined, the nineteenth and twentieth centuries gradually uncovered what actually produces it. Modern dermatology describes acne as the result of four interacting processes occurring at the pilosebaceous unit — the tiny structure where a hair follicle meets an oil-producing (sebaceous) gland. These four factors are: excess sebum production; follicular hyperkeratinization, in which skin cells lining the follicle multiply and stick together to plug the pore; colonization and activity of the skin bacterium now called Cutibacterium acnes; and inflammation. A plugged, oil-rich follicle (the microcomedone) is the seed; bacterial activity and the body's inflammatory response turn it into the visible papules, pustules, and nodules of acne.

This understanding was assembled piece by piece. Nineteenth-century investigators recognized that the lesions centred on the sebaceous follicles and that retained sebum and keratin formed the comedone (the "blackhead" or "whitehead"). The role of the sebaceous gland and its oily secretion became central to thinking about the disease. Late in the nineteenth century, as bacteriology matured in the wake of Pasteur and Koch, researchers identified bacteria within acne lesions and began to suspect a microbial contributor — the organism that would eventually be named for the disease it was found in.

It is worth stressing how these factors fit together, because the popular picture is often oversimplified. Acne is not a simple infection that one "catches," and it is not caused by poor hygiene; in fact the responsible bacterium is a normal resident of everyone's skin. Rather, acne emerges when hormonally driven oil production, an over-plugged follicle, the behaviour of that resident bacterium, and an inflammatory immune response all converge. Modern research has increasingly emphasized that inflammation may be present very early, even before a lesion is visible, reshaping the older idea of a strict step-by-step sequence into a more interconnected model.

Back to Table of Contents

The Bacterium: From Propionibacterium to Cutibacterium acnes

The microbe at the centre of acne has had several names, and its renaming is recent enough that older and newer textbooks disagree. The organism is a slow-growing, mostly anaerobic Gram-positive bacterium that lives harmlessly in the sebaceous follicles of essentially all human skin. After early bacteriological descriptions around the turn of the twentieth century, it was for many decades classified within the genus Propionibacterium (named for its ability to produce propionic acid) and known to generations of clinicians as Propionibacterium acnes.

In 2016, a detailed genomic and biochemical study by Scholz and Kilian, published in the International Journal of Systematic and Evolutionary Microbiology, reorganized the cutaneous propionibacteria and moved the acne organism into a newly proposed genus, Cutibacterium (from the Latin cutis, "skin"). Under this revision the bacterium became Cutibacterium acnes. The new name was widely, though not universally, adopted; some researchers and clinicians continued to use the older Propionibacterium acnes for a time, which is why both names appear in the literature. Today Cutibacterium acnes (often abbreviated C. acnes) is the standard term.

A crucial and often-missed point is that C. acnes is not a foreign invader but a normal part of the healthy skin's community of microbes. Its mere presence does not cause acne — it lives on people who never break out at all. Current research focuses on the idea that the balance among different strains (phylotypes) of C. acnes, and the way they interact with sebum and the immune system, matters more than the bacterium's simple presence or absence. This nuanced view has gradually replaced the older notion of acne as a straightforward bacterial infection, and it helps explain why simply killing the organism with antibiotics is neither a complete cure nor a sustainable long-term strategy.

Back to Table of Contents

The Hormonal Link: Androgens and the Sebaceous Gland

One of the most important twentieth-century insights was that acne is fundamentally tied to hormones — specifically to androgens, the class of sex hormones that includes testosterone and its more potent skin-active derivative, dihydrotestosterone (DHT). This connection explains the single most familiar fact about acne: that it characteristically begins at puberty, when androgen levels rise in both sexes. Androgens stimulate the sebaceous glands to enlarge and to produce more sebum, supplying the oily, follicle-plugging conditions in which acne develops.

This hormonal understanding did more than explain the timing of acne; it opened a whole therapeutic avenue. If androgens drive the sebaceous gland, then reducing androgen activity should reduce acne — and it does. Combined oral contraceptive pills, which alter the hormonal milieu and raise a protein that binds free testosterone, were found to improve acne in many women and are now an established treatment. Anti-androgen medications such as spironolactone, which blocks androgen receptors, likewise became a mainstay for hormonally driven acne, particularly in adult women. The recognition that the sebaceous gland is a hormone-responsive organ thus links the disease's biology directly to several of its most useful modern treatments.

The hormonal model also helped make sense of clinical patterns that puzzled earlier observers: why acne can flare with the menstrual cycle, why it appears in conditions associated with elevated androgens, and why certain anabolic-steroid or hormonal exposures can trigger or worsen it. Importantly, having acne does not mean a person's overall hormone levels are abnormal — in most people they are entirely normal, and the issue is how sensitively the skin's glands respond to ordinary hormones. This distinction matters for reassuring patients and for guiding when, if ever, hormonal testing is actually warranted.

Back to Table of Contents

Treatment Milestones: Peroxide, Antibiotics, and Isotretinoin

For most of history, acne treatment meant sulphur, mineral pastes, abrasive washes, and a great deal of unhelpful advice about diet and cleanliness. The modern therapeutic era began with a handful of genuinely effective agents. Benzoyl peroxide, a compound produced commercially in the United States from the 1920s, was proposed for acne-related skin conditions in the 1930s and, after decades of use, was formally approved for acne treatment in the United States around 1960. It remains a first-line, over-the-counter mainstay today, valued because it both reduces C. acnes and helps unplug pores — and notably because, unlike antibiotics, it does not breed bacterial resistance.

The arrival of antibiotics transformed acne care in the mid-twentieth century. Oral tetracycline became available for acne in the 1950s, and topical and oral antibiotics (tetracyclines such as doxycycline and minocycline, and topical agents such as clindamycin and erythromycin) became central to treatment for moderate inflammatory disease. Antibiotics work partly by suppressing C. acnes and partly through direct anti-inflammatory effects on the skin. Their heavy, prolonged use, however, drove the rise of antibiotic-resistant strains, and modern guidelines now stress limiting antibiotic duration and always combining them with benzoyl peroxide or a retinoid to protect their effectiveness.

The single most dramatic milestone was isotretinoin, a vitamin-A derivative (13-cis-retinoic acid) marketed under the original brand name Accutane. Following research in the late 1970s — notably work by dermatologist Gary Peck and colleagues at the U.S. National Cancer Institute reporting striking results in severe cystic acne — it was approved by the U.S. Food and Drug Administration in 1982 by Hoffmann-La Roche. Isotretinoin was genuinely transformative: it is the only treatment that acts on all four acne factors at once and can produce long-lasting or permanent clearing of even the most severe, scarring disease, which had previously been almost untreatable.

Isotretinoin's power came with a serious safety story that must be stated plainly. The drug is a potent teratogen — it causes severe birth defects if taken during pregnancy — a risk recognized around the time of its launch and confirmed by subsequent reports, including a U.S. Centers for Disease Control notice in the 1980s identifying it as a human teratogen. This led to its classification as a pregnancy Category X drug and, over the years, to strict pregnancy-prevention programs (in the United States, the iPLEDGE system) designed to ensure no one becomes pregnant while taking it. Isotretinoin also requires monitoring for other effects, and its possible relationship to mood has been the subject of ongoing study and debate. Its history is therefore a model of modern medicine's central trade-off: a remarkably effective drug whose benefits are real but whose use demands genuine care and informed consent.

Back to Table of Contents

Stigma, Psychology, and a More Humane Modern View

Throughout its long history, acne has carried a social and emotional burden out of all proportion to its physical danger. Because it appears on the face, during the self-conscious years of adolescence, and was for centuries wrongly blamed on dirtiness, immorality, diet, or poor character, people with acne have endured stigma, teasing, and shame. The old assumption that washing harder would fix it — an idea traceable all the way back to the ancient emphasis on bathing — not only failed but added a layer of self-blame, as if the condition were the sufferer's fault. None of this is supported by what we now understand: acne is a common, biologically driven condition that affects the great majority of people at some point, and it is not a sign of being unclean.

Modern dermatology takes the psychological dimension of acne seriously. Research has documented meaningful associations between acne — especially when persistent or severe — and lowered self-esteem, social anxiety, depression, and reduced quality of life, effects that can be as significant as those of other chronic medical conditions. Acne scarring, both the physical marks and their emotional echo, can last long after the active lesions resolve. Recognizing this has shifted the goal of treatment from a purely cosmetic concern to a legitimate part of caring for a person's overall well-being, and it underlies the modern push to treat significant acne early and effectively rather than dismissing it as a trivial phase.

The arc of this history, then, is not only scientific but humane. From an ancient affliction blamed on dirt and bad humours, acne has become a well-defined condition with a clear biology, a real toolkit of effective treatments, and an approach grounded in compassion rather than judgment. Anyone living with acne deserves accurate information, effective care, and freedom from the old shame — that, as much as any chemical or classification, is the worthwhile end of this thousand-year story.

Back to Table of Contents

Research Papers and References

The references below combine peer-reviewed sources on acne's history, pathophysiology, microbiology, and treatment with curated PubMed topic-search links for further reading. Ancient and early-modern primary sources (the Ebers Papyrus; the writings of Celsus, Galen, Aetius of Amida, and Theodorus Priscianus; and the dermatological treatises of Robert Willan and Thomas Bateman) are named in the article as historical sources rather than as modern citations. Each external link opens in a new tab.

  1. Scholz CFP, Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. International Journal of Systematic and Evolutionary Microbiology. 2016;66(11):4422-4432. — doi:10.1099/ijsem.0.001367
  2. Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. International Journal of Women's Dermatology. 2018;4(2):56-71. — doi:10.1016/j.ijwd.2017.10.006
  3. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2016;74(5):945-973. — doi:10.1016/j.jaad.2015.12.037
  4. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. The Lancet. 2012;379(9813):361-372. — doi:10.1016/S0140-6736(11)60321-8
  5. Tanghetti EA. The role of inflammation in the pathology of acne. The Journal of Clinical and Aesthetic Dermatology. 2013;6(9):27-35. — PubMed: PMID 24062871
  6. Layton AM. Top ten list of clinical pearls in the treatment of acne vulgaris. Dermatologic Clinics. 2016;34(2):147-157. — doi:10.1016/j.det.2015.11.008
  7. Holland C, Mak TN, Zimny-Arndt U, et al. Proteomic identification of secreted proteins of Propionibacterium acnes. BMC Microbiology. 2010;10:230. — doi:10.1186/1471-2180-10-230
  8. History of acne and rosacea (historical overview chapter). Pathogenesis and Treatment of Acne and Rosacea, Springer. — doi:10.1007/978-3-642-69375-8_1
  9. Acne pathogenesis — history of concepts. Dermatology. 2014;229(1):1-46. — doi:10.1159/000364860
  10. Mahmood NF, Shipman AR. The age-old problem of acne. International Journal of Women's Dermatology. 2017;3(2):71-76. — doi:10.1016/j.ijwd.2016.11.002
  11. History of acne — etymology, Aetius of Amida, and the development of the term — PubMed: acne history and etymology
  12. Isotretinoin in the treatment of severe acne — efficacy and teratogenicity — PubMed: isotretinoin acne and teratogenicity
  13. Robert Willan, Thomas Bateman, and the classification of cutaneous diseases — PubMed: Willan and Bateman history of dermatology
  14. Cutibacterium acnes taxonomy, skin microbiome, and acne pathogenesis — PubMed: Cutibacterium acnes and acne pathogenesis

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents